Associated Papers
ACE-Dependent Alzheimer's Disease: Circulating ACE Phenotypes in Heterozygous Carriers of Rare ACE Variants.
Mironenko IV et al.
International Journal of Molecular Sciences, 2025
41009662 (PubMed )
Supplement: ijms-26-09099-s001.zip › ijms-3824164-supplementary.pdf
Effects of Angiotensin-I-Converting Enzyme (ACE) Mutations Associated with Alzheimer's Disease on Blood ACE Phenotype.
Kryukova OV et al.
Biomedicines, 2024
39457722 (PubMed )
Supplement: biomedicines-12-02410-s001.zip › biomedicines-3224268-supplementary.pdf
Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer's Disease.
Danilov SM et al.
Biomedicines, 2024
38255267 (PubMed )
Supplement: biomedicines-12-00162-s001.zip › biomedicines-2780808-Supplementary.pdf
[Deficiency of 11beta-hydroxysteroid dehydrogenase type 2 (syndrome of apparent mineralocorticoid excess)].
Mune T
Nihon Rinsho. Japanese Journal of Clinical Medicine, 2006
11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
White PC et al.
Endocrine Reviews, 1997
Select a paper to view details